Should I buy or sell Sotera Health stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SHC shares. View SHC analyst ratings or view top-rated stocks .

What is Sotera Health's stock price target for 2024?

5 Wall Street research analysts have issued 1-year target prices for Sotera Health's shares. Their SHC share price targets range from $14.00 to $23.00. On average, they predict the company's share price to reach $17.70 in the next twelve months. This suggests a possible upside of 62.5% from the stock's current price. View analysts price targets for SHC or view top-rated stocks among Wall Street analysts .

How have SHC shares performed in 2024?

Sotera Health's stock was trading at $16.85 at the beginning of 2024. Since then, SHC stock has decreased by 35.4% and is now trading at $10.89. View the best growth stocks for 2024 here .

When is Sotera Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our SHC earnings forecast .

How can I listen to Sotera Health's earnings call?

Sotera Health will be holding an earnings conference call on Thursday, May 2nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link .

How were Sotera Health's earnings last quarter?

Sotera Health (NASDAQ:SHC) released its earnings results on Tuesday, February, 27th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.26. The company had revenue of $310.24 million for the quarter, compared to the consensus estimate of $302.17 million. Sotera Health had a trailing twelve-month return on equity of 51.32% and a net margin of 4.90%. Sotera Health's revenue was up 23.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 earnings per share.

What ETFs hold Sotera Health's stock?

ETFs with the largest weight of Sotera Health (NASDAQ:SHC) stock in their portfolio include WisdomTree U.S. SmallCap Fund (EES) and iShares Emergent Food and AgTech Multisector ETF (IVEG) . Invesco S&P MidCap 400 GARP ETF (EWMC) .

What guidance has Sotera Health issued on next quarter's earnings?

Sotera Health updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 0.670-0.750 for the period, compared to the consensus EPS estimate of 0.870. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

When did Sotera Health IPO?

Sotera Health (SHC) raised $1 billion in an initial public offering on Friday, November 20th 2020. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets acted as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.

How do I buy shares of Sotera Health?

Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:SHC

Sotera Health (SHC) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free SHC Stock Alerts

$10.89

-0.12 (-1.09%)

(As of 04/16/2024 ET)

Compare

Today's Range: $10.85
▼
$11.06
50-Day Range: $11.01
▼
$17.34
52-Week Range: $10.74
▼
$19.40

Volume: 773,883 shs
Average Volume: 1.64 million shs
Market Capitalization: $3.08 billion

P/E Ratio: 60.50
Dividend Yield: N/A
Price Target: $17.70

Get Sotera Health alerts:

Sotera Health MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.80 Rating Score
Upside/Downside: 62.5% Upside
$17.70 Price Target
Short Interest: Healthy
8.59% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.16
Based on 6 Articles This Week
Insider Trading: Selling Shares
$238.65 M Sold Last Quarter
Proj. Earnings Growth: 23.44%
From $0.64 to $0.79 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

60th out of 930 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

2nd out of 8 stocks

4.4

Analyst's Opinion

Consensus Rating
Sotera Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Sotera Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.0

Short Interest

Percentage of Shares Shorted
8.59% of the float of Sotera Health has been sold short.
Short Interest Ratio / Days to Cover
Sotera Health has a short interest ratio ("days to cover") of 6.3.
Change versus previous month
Short interest in Sotera Health has recently decreased by 6.22%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Sotera Health does not currently pay a dividend.
Dividend Growth
Sotera Health does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for SHC.

2.9

News and Social Media Coverage

News Sentiment
Sotera Health has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Sotera Health this week, compared to 2 articles on an average week.
Search Interest
6 people have searched for SHC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
MarketBeat Follows
2 people have added Sotera Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Sotera Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $238,654,624.00 in company stock.
Percentage Held by Insiders
65.13% of the stock of Sotera Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
91.03% of the stock of Sotera Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Sotera Health are expected to grow by 23.44% in the coming year, from $0.64 to $0.79 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Sotera Health is 60.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 138.17.
Price to Earnings Ratio vs. Sector
The P/E ratio of Sotera Health is 60.50, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 219.96.
Price to Book Value per Share Ratio
Sotera Health has a P/B Ratio of 6.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Sotera Health Stock (NASDAQ:SHC)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

SHC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SHC Stock News Headlines

March 16, 2024 | insidertrades.com

Pincus & Co. Warburg Sells 16,594,363 Shares of Sotera Health (NASDAQ:SHC) Stock

April 12, 2024 | stockhouse.com

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Sotera Health Company (SHC) of an Investigation

April 16, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 11, 2024 | globenewswire.com

Sotera Health Announces First-Quarter 2024 Earnings Release Date

April 11, 2024 | finance.yahoo.com

Sotera Health Company (NASDAQ:SHC) most popular amongst private equity firms who own 52% of the shares, institutions hold 29%

April 11, 2024 | americanbankingnews.com

Sotera Health (NASDAQ:SHC) Price Target Lowered to $14.00 at Barclays

April 8, 2024 | markets.businessinsider.com

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sotera Health Company (SHC)

April 8, 2024 | americanbankingnews.com

Sotera Health (NASDAQ:SHC) Receives $19.38 Average PT from Analysts

April 16, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

April 3, 2024 | markets.businessinsider.com

Analyst Scoreboard: 6 Ratings For Sotera Health

March 25, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sotera Health Company - SHC

March 11, 2024 | benzinga.com

A Glimpse Into The Expert Outlook On Sotera Health Through 4 Analysts

March 9, 2024 | benzinga.com

Massive Insider Trade At Sotera Health

March 7, 2024 | benzinga.com

Sotera Health Director Trades $158.28M In Company Stock

March 7, 2024 | benzinga.com

Director At Sotera Health Sells $237.42M Of Stock

March 6, 2024 | finance.yahoo.com

Sotera Health Company (NASDAQ:SHC) Q4 2023 Earnings Call Transcript

March 6, 2024 | finance.yahoo.com

Insider Sell: President of Sterigenics Michael Rutz Sells 83,109 Shares of Sotera Health Co (SHC)

March 1, 2024 | finance.yahoo.com

Sotera Health Company Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

February 29, 2024 | finance.yahoo.com

Sotera Health Full Year 2023 Earnings: EPS Misses Expectations

February 29, 2024 | markets.businessinsider.com

Sotera Health Announces Pricing Of Secondary Offering Of 25 Mln Shares At $14.75/shr

February 28, 2024 | globenewswire.com

Sotera Health Announces Pricing of Secondary Offering

February 28, 2024 | finance.yahoo.com

How Good Is Sotera Health Company (NASDAQ:SHC), When It Comes To ROE?

February 28, 2024 | finance.yahoo.com

Q4 2023 Sotera Health Co Earnings Call

February 27, 2024 | globenewswire.com

Sotera Health Announces Secondary Offering of Common Stock

February 27, 2024 | fool.com

Sotera Health (SHC) Q4 2023 Earnings Call Transcript

February 27, 2024 | finanznachrichten.de

Sotera Health Company: Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

February 27, 2024 | finance.yahoo.com

Sotera Health Co Reports Growth Amidst Challenges, Sets Positive Outlook for 2024

See More Headlines

Receive SHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sotera Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/27/2024
Today: 4/16/2024
Next Earnings (Confirmed): 5/02/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NASDAQ:SHC
CUSIP: N/A
CIK: 1822479
Web: www.soterahealth.com
Phone: 440-262-1410
Fax: N/A
Employees: 3,000
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $17.70
High Stock Price Target: $23.00
Low Stock Price Target: $14.00
Potential Upside/Downside: +62.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.80
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.18
Trailing P/E Ratio: 60.50
Forward P/E Ratio: 17.02
P/E Growth: N/A
Net Income: $51.38 million
Net Margins: 4.90%
Pretax Margin: 10.10%
Return on Equity: 51.32%
Return on Assets: 6.49%

Debt

Debt-to-Equity Ratio: 5.16
Current Ratio: 2.42
Quick Ratio: 2.21

Sales & Book Value

Annual Sales: $1.05 billion
Price / Sales: 2.94
Cash Flow: $1.27 per share
Price / Cash Flow: 8.57
Book Value: $1.57 per share
Price / Book: 6.94

Miscellaneous

Outstanding Shares: 283,070,000
Free Float: 98,707,000
Market Cap: $3.08 billion
Optionable: Optionable
Beta: 2.11

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Michael B. Petras Jr. (Age 55)
Chairman & CEO
Comp: $2.2M
Mr. Alexander Dimitrief (Age 65)
Senior VP, General Counsel & Secretary
Comp: $1.63M
Mr. Michael P. Rutz (Age 53)
President of Sterigenics
Comp: $715.73k
Mr. Jonathan M. Lyons (Age 46)
Senior VP & CFO
Mr. Robert G. Hauzie
Chief Information Officer
Joseph Vitale
Vice President of Investor Relations
Ms. Kristin A. Gibbs
Chief Marketing Officer
Mr. William O. Lehmann Jr. (Age 58)
J.D., M.B.A., Senior Vice President of Strategy & Corporate Development
Ms. Sally R. Turner
Chief Human Resources Officer
Ms. Kathleen A. Hoffman
Senior Vice President of Global Environmental, Health & Safety

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

SHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Sotera Health stock right now?: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sotera Health in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SHC shares.
View SHC analyst ratings or view top-rated stocks.
What is Sotera Health's stock price target for 2024?: 5 Wall Street research analysts have issued 1-year target prices for Sotera Health's shares. Their SHC share price targets range from $14.00 to $23.00. On average, they predict the company's share price to reach $17.70 in the next twelve months. This suggests a possible upside of 62.5% from the stock's current price.
View analysts price targets for SHC or view top-rated stocks among Wall Street analysts.
How have SHC shares performed in 2024?: Sotera Health's stock was trading at $16.85 at the beginning of 2024. Since then, SHC stock has decreased by 35.4% and is now trading at $10.89.
View the best growth stocks for 2024 here.
When is Sotera Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our SHC earnings forecast.
How can I listen to Sotera Health's earnings call?: Sotera Health will be holding an earnings conference call on Thursday, May 2nd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.
How were Sotera Health's earnings last quarter?: Sotera Health (NASDAQ:SHC) released its earnings results on Tuesday, February, 27th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.26. The company had revenue of $310.24 million for the quarter, compared to the consensus estimate of $302.17 million. Sotera Health had a trailing twelve-month return on equity of 51.32% and a net margin of 4.90%. Sotera Health's revenue was up 23.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.23 earnings per share.

What ETFs hold Sotera Health's stock?: ETFs with the largest weight of Sotera Health (NASDAQ:SHC) stock in their portfolio include WisdomTree U.S. SmallCap Fund (EES) and iShares Emergent Food and AgTech Multisector ETF (IVEG).Invesco S&P MidCap 400 GARP ETF (EWMC).
What guidance has Sotera Health issued on next quarter's earnings?: Sotera Health updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of 0.670-0.750 for the period, compared to the consensus EPS estimate of 0.870. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.
When did Sotera Health IPO?: Sotera Health (SHC) raised $1 billion in an initial public offering on Friday, November 20th 2020. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Credit Suisse, Goldman Sachs, Jefferies, Barclays, Citigroup and RBC Capital Markets acted as the underwriters for the IPO and BNP Paribas, Keybanc Capital Markets, Citizens Capital Markets and ING were co-managers.
How do I buy shares of Sotera Health?: Shares of SHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SHC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sotera Health (SHC) Stock Price, News & Analysis

Sotera Health MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Sotera Health Stock (NASDAQ:SHC)

SHC Stock Price History

SHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

SHC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™